INTEGRA LIFESCIENCES HOLDINGS CORP
IARTNext catalyst
BioDFence G3 Placental Tissue Membrane
Prostate Cancer
Get an email about IART's next catalysts
Track INTEGRA LIFESCIENCES HOLDINGS (IART) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
No other upcoming event in our data.
1 upcoming, 3 past
BioDFence G3 Placental Tissue Membrane Phase 2 Est. Readout (HAMMER)
Estimated primary completion for BioDFence G3 Placental Tissue Membrane trial (NCT05842057) in Prostate Cancer. Topline data typically follows completion by weeks to months.
SourceMarket Overview
Stock performance and key metrics
Picosulfate sodium, magnesium oxide, citric acid
Bowel Preparation Before Colonoscopy
Quiklean® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP)
Bowel Preparation
NorLeu3-A(1-7) in a gel formulation
Foot Ulcer, Diabetic
BioDFence G3 Placental Tissue Membrane
Prostate Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Picosulfate sodium, magnesium oxide, citric acid | Phase 3 | Bowel Preparation Before Colonoscopy | - | - |
Quiklean® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) | Phase 3 | Bowel Preparation | - | - |
NorLeu3-A(1-7) in a gel formulation | Phase 2 | Foot Ulcer, Diabetic | - | - |
BioDFence G3 Placental Tissue Membrane | Phase 2 | Prostate Cancer | - | - |
Frequently asked questions
What is in INTEGRA LIFESCIENCES HOLDINGS CORP's drug pipeline?→
CatalystAlert tracks 4 drug candidates in INTEGRA LIFESCIENCES HOLDINGS CORP's (IART) pipeline across Phase 3, Phase 2. Its lead program is Picosulfate sodium, magnesium oxide, citric acid (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is INTEGRA LIFESCIENCES HOLDINGS CORP's next FDA catalyst?→
INTEGRA LIFESCIENCES HOLDINGS CORP's (IART) next tracked catalyst is a Phase 2 readout expected Q3 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track IART biotech catalysts?→
Add IART to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow INTEGRA LIFESCIENCES HOLDINGS CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.